Baxter Intl is a big company that makes medical stuff. Some people who know a lot about money think this company will do well in the future, so they are buying options to make more money if Baxter's stock goes up. Options are like bets on how much a stock will change in price. So, these smart people are making big bets that Baxer's stock will go up and they can earn more money from it. Read from source...

1. The title is misleading and sensationalist. It suggests that there was some extraordinary or unexpected event that occurred in Baxter Intl's options market, but the article does not provide any evidence or explanation for what constitutes "unusual" activity. A more accurate title would be something like "Some Financial Giants Show Interest in Baxter Intl's Options".
2. The article uses vague and imprecise language throughout. For example, it says that the analysis of options history revealed 8 "unusual" trades, but what does that mean? How are these trades defined as unusual? What criteria or methodology was used to identify them? The article does not provide any details or clarification on this matter, leaving the reader with a lot of unanswered questions.
3. The article makes sweeping generalizations and assumptions based on limited data. It claims that 75% of traders were bullish and 25% bearish, but how does it know that? What is the source and sample size of this information? How can the author be so certain about the sentiment of thousands of traders without any supporting evidence or analysis? This smacks of confirmation bias and overconfidence.
4. The article lacks objectivity and balance. It only presents one side of the story, that is, the bullish perspective. It does not mention any possible drawbacks, risks, or challenges that Baxter Intl may face in the future. It also does not consider alternative views or scenarios that could impact the stock price negatively. The article seems to have a predetermined agenda and tries to persuade the reader to buy the stock based on emotional appeals rather than rational arguments.
5. The article is outdated and irrelevant. It was written in May 2, 2024, almost two years ago. A lot has changed since then in the market, the company, and the world. The information and opinions presented in the article are likely to be stale, inaccurate, or obsolete. A more reliable and current source of information would be needed to make an informed decision about Baxter Intl's options.

1. Buy BAX at its current price ($83.60 as of May 2, 2024) and set a stop-loss order at $79.00 to minimize potential losses in case of a sudden market downturn.
2. Consider selling covered calls on BAX with a strike price of $85.00 or higher, which would generate additional income and reduce your cost basis if the stock reaches those levels before expiration.
3. Monitor the options activity closely and be prepared to adjust your strategy based on any significant changes in market sentiment or news developments related to Baxter Intl.